Sign In

Alexander Shneider

Founder and CEO, CureLab Oncology, Inc.

Alexander Shneider is a prominent figure in the biotech industry with over 25 years of experience in entrepreneurship and scientific research. He is currently the Founder and CEO of CureLab Oncology, a company focused on immune-oncology.12

Professional Background

Dr. Shneider holds a Ph.D. and serves as a Senior Research Fellow of molecular biology at the University of Ariel in Israel.1 His extensive experience includes:

  • Drug development from concept to market authorization
  • Securing patents in major jurisdictions
  • Advisory roles for successful company exits
  • Consulting for Fortune 100 companies
  • Establishing and leading international R&D consortia
  • Senior authorship in scientific papers and books

Academic and Editorial Roles

In addition to his entrepreneurial pursuits, Dr. Shneider maintains active involvement in academic and scientific publishing:

  • Editorial board member for the journals Aging and Cell Cycle15
  • Has held professor-level positions at two international universities4

Other Positions

  • Advisor at We Fund Health1
  • Chairman of the Board at CureLab Oncology3

Dr. Shneider's expertise spans various areas of biotechnology, with a particular focus on cancer research and treatment. His work at CureLab Oncology aims to address the growing burden of cancer, particularly in the Asia-Pacific region.2

Related Questions

What are Alexander Shneider's main research interests?
How did Alexander Shneider transition from academia to biotech entrepreneurship?
What are some notable achievements of Alexander Shneider in drug development?
How does Alexander Shneider's work at CureLab Oncology impact aging research?
What are Alexander Shneider's contributions to the journal Aging?
Alexander Shneider
Alexander Shneider, photo 1
Alexander Shneider, photo 2
Add to my network

Location

Greater Boston